NEW YORK, July 1, 2015 /PRNewswire/ -- Morgan & Morgan announces that it is investigating potential claims against the board of directors of Towers Watson & Co. ("Towers Watson" or the "Company") (NasdaqGS: TW) for potential breaches of fiduciary duties in connection with the sale of the Company to Willis Group Holdings PLC for approximately $18 billion.
If you purchased Towers Watson stock, and want more information about the Towers Watson takeover investigation, please contact Morgan & Morgan at 1(800) 732-5200 or email email@example.com.
Under the terms of the transaction, Towers Watson stockholders will only receive $4.87 in cash and 2.6490 Willis shares for each Towers Watson share of common stock they own. The total deal consideration per share would be approximately $125.13 per share of Towers Watson. However, at least on analyst has set a price target of $157.00 per share of Towers Watson.
Morgan & Morgan's investigation concerns whether the board of directors of Towers Watson breached its fiduciary duties to act in the best interests of Towers Watson shareholders.
About Morgan & Morgan
Morgan & Morgan is one of the nation's largest 200 law firms. In addition to shareholder rights, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability. All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."
Attorney advertising. Prior results do not guarantee a similar outcome.
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
New York, NY 10036
SOURCE Morgan & Morgan